Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T35792 | Target Info | |||
Target Name | Histone-lysine N-methyltransferase SMYD3 (SMYD3) | ||||
Synonyms | SET and MYND domain-containing protein 3; Zinc finger MYND domain-containing protein 1 | ||||
Target Type | Preclinical Target | ||||
Gene Name | SMYD3 | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Sinefungin | Ligand Info | |||
Canonical SMILES | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CC(CCC(C(=O)O)N)N)O)O)N | ||||
InChI | 1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1 | ||||
InChIKey | LMXOHSDXUQEUSF-YECHIGJVSA-N | ||||
PubChem Compound ID | 65482 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3PDN Crystal structure of SmyD3 in complex with methyltransferase inhibitor sinefungin | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [1] |
PDB Sequence |
EPLKVEKFAT
11 ANRGNGLRAV21 TPLRPGELLF31 RSDPLAYTVC41 KGSRGVVCDR51 CLLGKEKLMR 61 CSQCRVAKYC71 SAKCQKKAWP81 DHKRECKCLK91 SCKPRYPPDS101 VRLLGRVVFK 111 LMDGAPSESE121 KLYSFYDLES131 NINKLTEDRK141 EGLRQLVMTF151 QHFMREEIQD 161 ASQLPPAFDL171 FEAFAKVICN181 SFTICNAEMQ191 EVGVGLYPSI201 SLLNHSCDPN 211 CSIVFNGPHL221 LLRAVRDIEV231 GEELTICYLD241 MLMTSEERRK251 QLRDQYCFEC 261 DCFRCQTQDK271 DADMLTGDEQ281 VWKEVQESLK291 KIEELKAHWK301 WEQVLAMCQA 311 IISSNSERLP321 DINIYQLKVL331 DCAMDACINL341 GLLEEALFYG351 TRTMEPYRIF 361 FPGSHPVRGV371 QVMKVGKLQL381 HQGMFPQAMK391 NLRLAFDIMR401 VTHGREHSLI 411 EDLILLLEEC421 DANIRAS
|
|||||
|
ASN13
4.372
ARG14
2.725
GLY15
3.714
ASN16
2.795
TYR124
2.647
ASP128
4.838
LEU129
4.785
GLU130
3.567
ASN132
2.919
CYS180
3.697
ASN181
3.029
|
|||||
PDB ID: 3RU0 Cocrystal structure of human SMYD3 with inhibitor Sinefungin bound | ||||||
Method | X-ray diffraction | Resolution | 1.85 Å | Mutation | No | [2] |
PDB Sequence |
LKVEKFATAN
13 RGNGLRAVTP23 LRPGELLFRS33 DPLAYTVCKG43 SRGVVCDRCL53 LGKEKLMRCS 63 QCRVAKYCSA73 KCQKKAWPDH83 KRECKCLKSC93 KPRYPPDSVR103 LLGRVVFKLM 113 DGAPSESEKL123 YSFYDLESNI133 NKLTEDKKEG143 LRQLVMTFQH153 FMREEIQDAS 163 QLPPAFDLFE173 AFAKVICNSF183 TICNAEMQEV193 GVGLYPSISL203 LNHSCDPNCS 213 IVFNGPHLLL223 RAVRDIEVGE233 ELTICYLDML243 MTSEERRKQL253 RDQYCFECDC 263 FRCQTQDKDA273 DMLTGDEQVW283 KEVQESLKKI293 EELKAHWKWE303 QVLAMCQAII 313 SSNSERLPDI323 NIYQLKVLDC333 AMDACINLGL343 LEEALFYGTR353 TMEPYRIFFP 363 GSHPVRGVQV373 MKVGKLQLHQ383 GMFPQAMKNL393 RLAFDIMRVT403 HGREHSLIED 413 LILLLEECDA423 NIRAS
|
|||||
|
ARG14
2.720
GLY15
3.727
ASN16
2.808
TYR124
2.669
ASP128
4.573
LEU129
4.993
GLU130
3.728
ASN132
2.991
CYS180
3.376
ASN181
2.880
SER202
2.898
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural insights into the autoinhibition and posttranslational activation of histone methyltransferase SmyD3. J Mol Biol. 2011 Feb 11;406(1):149-59. | ||||
REF 2 | Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS One. 2011;6(7):e22290. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.